|Back Zoom + Zoom -|
Oxford, AstraZeneca Reviewing Need to Adjust Covid Vaccine Against Mutants: Report
Oxford scientists are gearing up to rapidly make new versions of a COVID-19 vaccine co-developed with AstraZeneca (AZN.US) to fight variants emerging in Britain, South Africa and Brazil, reported The Telegraph.
An Oxford spokesman told Reuters the university is carefully reviewing mutants' impact on vaccine immunity, and whether a rapid vaccine adjustment should be necessary.
AAStocks Financial News
Web Site: www.aastocks.com